Lemtrada
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Alemtuzumab (Lemtrada) is a recombinant humanized IgG1 kappa monoclonal antibody to the surface cell glycoprotein, a CD52…
Background There is a significant UK variation in the DMT sequencing strategies for high PML risk patients on Tysabri. In Greater…
Stwardnienie rozsiane cześciej wystepuje u kobiet, a szczyt zachorowan przypada na wiek rozrodczy. Dlatego zagadnienie ciązy w…
From 1 April 2015, Lemtrada (alemtuzumab) became available in Australia on the PBS for the treatment of relapsing forms of…
NEW DRUG APPROVALS Blincyto for Rare Form of ALL The FDA has approved blinatumomab (Blincyto, Amgen) to treat patients with…